Genetic Testing Program Lowered Age of Molecular Diagnosis in Children

Genetic Testing Program Lowered Age of Molecular Diagnosis in Children

284901

Genetic Testing Program Lowered Age of Molecular Diagnosis in Children

By implementing a free-of-charge epilepsy genetic testing program, it is possible to lower the average age of molecular diagnosis of children with epileptic disorders caused by mutations in the SCN1A gene, such as Dravet syndrome, from more than 6 to less than 2 years of age. The study with that finding, “Reducing the Time to Diagnosis and Increasing the Detection of Individuals With SCN1A-Related Disease Through a No Cost, Sponsored Epilepsy Genetic Testing Program,” was…

You must be logged in to read/download the full post.